Paydirt
FT
Insider

Frank Torti

President and Vant Chair · Roivant Sciences

Frank Torti (President and Vant Chair) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $82.0M of ROIV (3,000,000 sh across 3 lots, as filed), executed Feb 19. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$82.0M
shares × price, as filed
Last traded
Feb 23
Filed Feb 23

Median ADV $222.0M across their filed names

Open performance→
Volume by month
$82.0M$41.0M$0Dec 2024Jun 2025Dec 2025Jun 2026Feb 2026 · sells $82.0M
Buys $0 Sells $82.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
ROIV Roivant Sciences Ltd. ROIV · 0 buys · 1 sell 1 filing
Recent filings
ROIVSALE Roivant Sciences Ltd. View filing → $82.0M
3,000,000 sh across 3 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET